Friday, September 3, 2010
"Concise industry news from the US pharmaceutical industry..."
Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Blog
Where our team of guest writers discuss what they think about the current NGP US Issues.
Peter Duncan
Director of Business Development
Director of Business Development
Can digital pathology save drug development?
Peter Duncan of Definiens discusses the potential of digital pathology.07 Jul 2010
Focus Areas
Cover Stories
Pharma Needs You!
Pharma firms are finding it increasingly difficult to rapidly recruit patients for clinical trials and many are turning to internet tools and...
The Secret eDiary of Adrian's
eDiaries and other ePRO solutions are changing the face of clinical trials. They increase compliance and decrease false data - and they're the...
Roundtables
-
Target Acquired
Ambion's David Dorris and Qiagen's Walter Tian on how to exploit the benefits of RNAi.Read more -
Gene Genies
Jay Flatley, Illumina, and Doug Amorese, Agilent, go head-to-head on one of pharma's hottest topics.Read more -
Trials and Tribulations
Under pressure? John W, Hubbard, ICON Clinical Research, Diana L. Anderson, DL Anderson International, Inc., Lance Nickens, The Patient Recruiting Agency, and Elizabeth...Read more -
Easy Does It
Phoenix Data Systems' William Claypool, Phaseforward's Paul Bleicher, Fast Track's Ed Seguine, and Achim Schuelke of VIASYS Healthcare Inc. on being as easy as EDC.Read more
Vendor Perspectives
-
Optimizing Efficiency with Electronic Re...
A large generic pharmaceutical company has research, development, manufacturing and distribution operations worldwide. By WatersRead more -
RNAi Goes Genomic: Target Identification...
By Ellen Prediger, PhD, Director, Scientific Communication, and Kathy Latham, PhD, Marketing Manager, Ambion, Inc.Read more
Industry Analysts
-
Breaking New Ground
Jerry Moy of Siemens Business Services talks RFID and the pharmaceutical supply chain.Read more -
Business Insights for the Demand-driven En...
John McGrory of Edge Dynamics on achieving channel control and becoming a demand-driven enterprise.Read more
Executive Interviews
On the Record
Talking with Matthew J. Toussant, Ph.D, Vice President, Editorial Operations, CAS.
Read more
Size Matters
How the tiny world of nanotechnology is having a big impact on the pharma industry. By Magforce Nanotechnologies AG
Read more
Standard Issue
NGP speaks with Professor Antony N Davies, Senior Marketing Manager, Waters Informatics about how the use of standards is a powerful enabling technology for moving information cleanly and in a compliant manner between applications.
Read more
Next Generation Healthcare Summit
25th - 27th October 2010
As healthcare costs continue to rise, health providers around the country feel a sharp sense of urgency in deploying information technology to lower costs, reduce medical errors, enhance outcomes, and spur efficiency in an industry known for legendary inefficiency.
Source: www.ngpharma.com© 2010 GDS Publishing Ltd. All rights reserved.